GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Global Longlife Hospital and Research Ltd

Global Longlife Hospital Board Approves Business Diversification and Name Change

RESULTS ◆ Monitor Closely HIGH RISK
📅 Filed on BSE: 07 May 2026, 03:54 PM IST  ·  BSE ID: dbffcfbc-30c8-4732-b8ae-fe5e5d21a605
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board decided to switch its main business from hospitals to trade and services, and change its name, after reporting a yearly loss.
🤖 AI Summary
  • Board approved Audited Financial Results for Half Year and Year ended March 31, 2026.
  • Company reported a Net Loss of Rs. 171.95 Lakhs for the year ended March 31, 2026.
  • Main Object Clause of MOA to be altered, shifting from healthcare to trade and service industry.
  • Name change approved to Kanzi Enterprise Limited, Asahi Enterprise Limited, or Siddhaa Enterprise Limited.
  • All alterations are subject to shareholder and Ministry of Corporate Affairs approvals.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Net Profit/(Loss) for Year Ended March 31, 2026
(171.95) Lakhs
Net Profit/(Loss) for Half Year Ended March 31, 2026
(39.61) Lakhs
Revenue from Operations for Year Ended March 31, 2026
0.00 Lakhs
Other Income for Year Ended March 31, 2026
0.52 Lakhs
🏢 How This Affects the Company
📈
Business Impact
The company plans to completely exit the healthcare sector, deleting its existing main object clause and adding a new one for the trade and service industry. This represents a fundamental shift in business operations and strategic focus.
💰
Financial Impact
The company reported a Net Loss of Rs. 171.95 Lakhs for the year ended March 31, 2026. This financial performance is observed ahead of the announced business diversification.
⚙️
Operational Impact
Operations will transition from healthcare to trade and services, requiring new operational frameworks and resource allocation. The existing healthcare infrastructure and expertise will no longer be the primary focus.
⚠️
Risk Impact
The transition to a new industry introduces execution risk, as the company will operate in an unfamiliar sector. Regulatory approvals for name and object clause changes are also required.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will be required to approve the alteration of the company's name clause and the main object clause of the Memorandum of Association.
👤
Who Is Affected
All existing shareholders will be affected by the proposed change in the company's business focus and name. The company’s identity will change from a healthcare entity to a trade and service entity.
🔍
Management Signal
The Board's decision signals a fundamental strategic repositioning of the company, moving away from its previous healthcare operations towards a new business segment.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder meeting date for MOA and name change approval.
Ministry of Corporate Affairs approval status for name and object clause changes.
Filings related to new business operations in trade and service industry.
HIGH RISK Company's plan for a complete business pivot introduces significant execution and operational transition risk.
💡 Investor Takeaway
The Board approved Audited Financial Results, showing a Net Loss of Rs. 171.95 Lakhs for FY26. A strategic shift from healthcare to trade and service industry is planned, along with a name change, pending shareholder and regulatory approvals.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Company reported a Net Loss of Rs. 171.95 Lakhs for the year ended March 31, 2026.
  • Revenue from Operations for the year ended March 31, 2026, was Rs. 0.00 Lakhs, indicating no operational revenue from its stated business.
📅 Company Track Record
Past filings indicate Global Longlife Hospital and Research Ltd. had previously reported a loss of Rs. 171.95 Lakhs and plans to exit healthcare for trade/service, aligning with the current filing's strategic direction.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.